Biography
Dr. Smith received her training in molecular and cellular biology, epidemiology, and the genetics and genomics of complex traits. Her current research focuses on integrating human genetics with ‘omics data to better understand disease mechanism, disease severity and progression, and pharmaceutical safety liabilities. She is active in multiple pre-competitive collaborations to generate large data sets to enable these efforts, such as the UK Biobank Pharma Proteomics Project, and is actively working to apply this data to improve the discovery and translation of therapeutics for gastrointestinal and neurodegenerative disease.
Track Chair: Cindy Lawley, Olink